Sign inGet started

Kim Christopher

Insider CIK 2040022 · APUS Chairman and CMO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
APUS Apimeds Pharmaceuticals US A Award deriv2025-10-152025-10-173,000— $03,000SEC↗
APUS Apimeds Pharmaceuticals US A Award2025-05-162025-05-20250,000— $0277,500SEC↗
APUS Apimeds Pharmaceuticals US P Buy2025-05-142025-05-157,730$1.86 $14.4K27,500SEC↗
APUS Apimeds Pharmaceuticals US P Buy2025-05-132025-05-1519,770$1.82 $36.0K19,770SEC↗